Flexible Production: Meeting The Growing Demands Of The Biotechnology Sector

By Matthias Angelmaier

New vaccines employing biotech innovations are changing the way we prevent illness. However, they also lead to a number of challenges: vaccines must be developed, produced, and delivered with a short time to market, while process costs must be kept down without compromising patient and employee safety.

In view of ongoing growth, biotechnology pioneer Bavarian Nordic decided to expand its production capabilities and built a new production facility at its site in Kvistgård, Denmark. The goal of the investment was to create a processing line to freeze-dry active substances in order to extend their shelf life, and to process their liquid products while generally enhancing their capacities for contract filling services. It was important to them to use reliable and proven standard machines to ensure high product quality. In addition, the line had to be as compact as possible to reduce facility footprint, and as flexible as possible to fill a wide variety of vial formats.

With state-of-the-art technology and expertise from Syntegon Technology, they successfully installed a new isolator filling line for freeze-dried and liquid vaccine serums.